Univest
Univest
  • Markets

Dhampur Bio Organics Share Price Falls 3.85% After Q1 Results as Core Business Posts a Loss

  • July 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Dhampur Bio Organics Share Price Falls
 

Dhampur Bio Organics share price -3.85% to Rs 113.61. Q1 FY27 consolidated profit Rs 36.79cr aided by Rs 63.89cr exceptional gain. Standalone loss Rs 12.14cr.

The Dhampur Bio Organics share price fell 3.85 percent on 15 July 2026 after the bio sugar and chemicals producer reported mixed Q1 FY27 results, with a standalone net loss in its core continuing operations even as total consolidated profitability was lifted by a large one time asset sale gain. The Dhampur Bio Organics share price reaction underscores how markets look past headline profit numbers when exceptional items are involved.

Click Here – Get Free Investment Predictions

Dhampur Bio Organics reported a consolidated Profit for the Period of Rs 36.79 crore in Q1 FY27, but this headline figure was driven almost entirely by a Rs 63.89 crore exceptional gain from the sale of an undertaking, since the company’s continuing operations posted a pre-tax loss of Rs 1.71 crore for the quarter. On a standalone basis, the company reported a net loss of Rs 12.14 crore, compared with a profit of Rs 38.14 crore in the preceding March 2026 quarter and a loss of Rs 11.46 crore in Q1 FY26. This mixed picture is central to understanding the Dhampur Bio Organics share price move on results day.

Consolidated revenue from operations grew a healthy 22.37 percent year on year to Rs 918.56 crore, up from Rs 750.64 crore in Q1 FY26, showing that the top line expansion was not the concern for investors, who instead focused on the underlying operating loss once the one time gain is excluded.

Table of Contents

Toggle
  • Why the Dhampur Bio Organics share price Fell Despite the Consolidated Profit Headline
  • What Investors Should Watch Next
  • Conclusion
  • FAQs
    • Why did the Dhampur Bio Organics share price fall after Q1 results?
    • What was Dhampur Bio Organics’ Q1 FY27 consolidated profit?
    • Did Dhampur Bio Organics’ core business make a profit in Q1 FY27?
    • What was Dhampur Bio Organics’ Q1 FY27 revenue?
    • Why is the exceptional gain excluded when assessing Dhampur Bio Organics’ results?
    • Should investors buy Dhampur Bio Organics after this decline?

Why the Dhampur Bio Organics share price Fell Despite the Consolidated Profit Headline

The Dhampur Bio Organics share price decline to Rs 113.61, down from a previous close of Rs 118.16, reflects investor recognition that the headline consolidated profit figure was not representative of the core sugar and chemicals business, which continued to post an operating loss during the quarter.

Markets typically discount exceptional, non recurring items such as gains on asset sales when assessing a company’s underlying earnings quality, which explains why the Dhampur Bio Organics share price declined even though the total reported profit figure appeared positive on a consolidated basis.

What Investors Should Watch Next

Investors tracking the Dhampur Bio Organics share price should focus on the trajectory of the continuing operations loss and management commentary on cost control measures in the core bio sugar and chemicals business over the coming quarters.

The proceeds from the asset divestment that drove the exceptional gain could also be deployed toward debt reduction or capacity investments, and any such capital allocation update would be an important data point for the Dhampur Bio Organics share price going forward.

Conclusion

The Dhampur Bio Organics share price decline of 3.85 percent reflects investor focus on the underlying operating loss in the core business, even as the company reported a positive consolidated profit driven by a one time asset sale gain. Investors tracking the Dhampur Bio Organics share price should watch the continuing operations trajectory and consult a SEBI-registered investment advisor before making any investment decision.

Learn More About Univest, a SEBI Registered Investment Advisor

Download the Univest iOS App or Univest Android App to track live Dhampur Bio Organics price movements and get expert research.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

Why did the Dhampur Bio Organics share price fall after Q1 results?

Ans. The Dhampur Bio Organics share price fell 3.85 percent as investors focused on the standalone net loss of Rs 12.14 crore in the core business, even though consolidated profit of Rs 36.79 crore was reported, driven by a Rs 63.89 crore one time asset sale gain.

What was Dhampur Bio Organics’ Q1 FY27 consolidated profit?

Ans. Dhampur Bio Organics reported a consolidated Profit for the Period of Rs 36.79 crore in Q1 FY27, though this was driven largely by a Rs 63.89 crore exceptional gain from the sale of an undertaking rather than core operations.

Did Dhampur Bio Organics’ core business make a profit in Q1 FY27?

Ans. No, Dhampur Bio Organics’ continuing operations posted a pre-tax loss of Rs 1.71 crore in Q1 FY27, and on a standalone basis the company reported a net loss of Rs 12.14 crore for the quarter.

What was Dhampur Bio Organics’ Q1 FY27 revenue?

Ans. Dhampur Bio Organics’ consolidated revenue from operations grew 22.37 percent year on year to Rs 918.56 crore in Q1 FY27, up from Rs 750.64 crore in Q1 FY26.

Why is the exceptional gain excluded when assessing Dhampur Bio Organics’ results?

Ans. Markets typically discount one time, non recurring items such as gains on asset sales when assessing a company’s underlying earnings quality, since these gains do not reflect the sustainable profitability of the core business.

Should investors buy Dhampur Bio Organics after this decline?

Ans. This article is for informational purposes only. Investors should evaluate the trajectory of the core business’s continuing operations and consult a SEBI-registered investment advisor before making any investment decision.

 



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply